New Humana partnership aims to improve preauthorization in 12 states
Humana is partnering with digital healthcare company Cohere Health to change the prior authorization process for musculoskeletal treatment in 12 states.
Musculoskeletal treatment affects bones, muscles, ligaments, tendons and nerves. Beginning Jan. 1, Humana will use Cohere’s technology to grant authorizations from initial diagnosis to treatment plan selection, or across the entire episode of care, for musculoskeletal conditions.
About 2 million members and 3,500-plus physicians will have access to the process.
The new musculoskeletal prior authorization process will be deployed in Alabama, Georgia, Indiana, Kentucky, Michigan, North Carolina, Ohio, Pennsylvania, South Carolina, Tennessee, Virginia and West Virginia.
Share:
About the Author: Cohere Health
Cohere Health is a clinical intelligence company delivering AI-powered intelligent prior authorization solutions, which streamlines patients’ access to quality care by aligning their physicians and health plans for improved collaboration, transparency, and care coordination. Cohere works with nearly 600,000 providers and processes more than 12 million prior authorization requests annually, using AI to auto-approve up to 90% of requests for millions of health plan members around the country. The company was recognized twice in the Gartner® Hype Cycle™ for U.S. Healthcare Payers, is a Top 5 LinkedIn™ Startup for 2023 & 2024, and is a three-time KLAS Points of Light award recipient. Its investors include Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital, and Polaris Partners.
